Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Global Stomach Cancer Treatment Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. ... Read More
-
Global Next Generation Cancer Diagnostics Databank Market Report
... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More
-
Global Anti-Cancer Drug Databank Market Report
... 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy ... Read More
-
Global Cancer Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More
-
Global Brain Cancer Diagnostics Databank Market Report
... 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Castrate-resistant Prostate Cancer Databank Market Report
... 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. ... Read More
-
Global Cancer Registry Software Databank Market Report
... from 2023 to 2031. Integrated segment is expected to be the highest contributor to this market, with $35.1 Million in 2022, and is anticipated to reach $42.9 Million by 2031, registering a CAGR of 2.28%. Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Biomarkers Market by Product & Service (Consumable, Software), Type (Safety, Efficacy), Research Area, Technology (NGS, PCR, Mass Spectrometry), Disease (Cancer, Infectious), Application (Diagnostics, Clinical Research) - Global Forecast to 2029
... to reach USD 93.8 billion in 2029 from USD 57.7 billion in 2024, at a CAGR of 10.2% during the forecast period. The growth of this market can be attributed to the advantage that these ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Loop Electrosurgical Excision Procedure (LEEP) Market Growth (Status and Outlook) 2024-2030
... cervical cell changes (abnormal cells) or early stage cervical cancer, as well as to diagnose cervical cancer. The global Loop Electrosurgical Excision Procedure (LEEP) market size is projected to grow from US$ million in 2023 ... Read More
-
Targeted Cancer Therapeutics Market Size, Trends, Analysis, and Outlook By Therapy (Small Molecule Drugs, Monoclonal Antibodies, Immunotherapies, Others), By Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Blood Cancer, Gynecologic Cancer, Others), By End-User (Hospitals, Cancer and Radiation Therapy Centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032
... and Radiation Therapy Centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032 The global Targeted Cancer Therapeutics market size is poised to register 6.6% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Viral Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenoviral Vectors, Aden-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Application (Gene Therapy, Vaccinology), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Viral Vector Manufacturing market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Cervical Cancer Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Others), By Therapeutics (Avastin (Bevacizumab), Blenoxane (Bleomycin), Hycamtin (Topotecan Hydrochloride), Gemcitabine-Cisplatin, Vaccines, Others), By End-User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers), by Country, Segment, and Companies, 2024-2032
... Vaccines, Others), By End-User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers), by Country, Segment, and Companies, 2024-2032 The global Cervical Cancer Diagnostics and Therapeutics market size is poised to register 4.2% growth ... Read More
-
Pancreatic and Biliary Stents Market Size, Trends, Analysis, and Outlook By Product (Plastic Stents, Metal Stents), By Application (Benign Biliary Structures, Bili-Pancreatic Leakages, Pancreatic Cancer, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by Country, Segment, and Companies, 2024-2032
... Segment, and Companies, 2024-2032 The global Pancreatic and Biliary Stents market size is poised to register 5.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Minimal Residual Disease Testing Market Size, Trends, Analysis, and Outlook By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Others), By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Others), By End-User (Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Minimal Residual Disease Testing market size is poised to register 14.8% growth from 2024 to 2032, presenting significant ... Read More
-
Vaccine Adjuvants Market Size, Trends, Analysis, and Outlook By Product (Adjuvant Emulsions, Pathogen Components, Saponin-based adjuvants, Particulate Adjuvants, Others), By Route of Administration (Intramuscular, Subcutaneous, Others), By Disease (Infectious Diseases, Cancer, Others), By Application (Research Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032
... Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032 The global Vaccine Adjuvants market size is poised to register 13.7% growth from 2024 to 2032, presenting significant ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Viral Vectors, Plasmid DNA), By Products and Services (Product, Services), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Cell and Gene Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Viral Vector and Plasmid ... Read More
-
Theranostics Market Size, Trends, Analysis, and Outlook By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers), by Country, Segment, and Companies, 2024-2032
... and Academic Centers), by Country, Segment, and Companies, 2024-2032 The global Theranostics market size is poised to register 10.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
Minimal Residual Disease Market Size, Trends, Analysis, and Outlook By Test, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Next Generation Sequencing (NGS)), By Detection Target (Leukemia, Lymphoma, Solid Tumors, Others), By End-User (Hospitals, Laboratory centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032
... centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032 The global Minimal Residual Disease market size is poised to register 12.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the ... Read More
-
Fluorescent In Situ Hybridization Market Size, Trends, Analysis, and Outlook By Probe (Locus Specific Probes, Alphoid/Centromere Repeat Probes, Whole Chromosome Probes), By Application (Cancer Research, Genetic Diseases, Others), By End-User (Research Organizations, Clinical Organizations, Biotechnology Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032
... Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032 The global Fluorescent In Situ Hybridization market size is poised to register 8.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
Research Assistance
